4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-24-000024
Options or other derivatives
- Chief Legal Officer acquired 174,850 shares (grant or award)
- Chief Legal Officer returned 174,850 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Siegel Jolie · Chief Legal Officer
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-07 | Returned to the company : show line 1 in the form Stock Option (Right to Buy) | −84,850 | 0 | D |
| 2024-03-07 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +84,850 | 84,850 | D |
| 2024-03-07 | Returned to the company : show line 3 in the form Stock Option (Right to Buy) | −90,000 | 0 | D |
| 2024-03-07 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +90,000 | 90,000 | D |
Loading xslF345X05/wk-form4_1709943540.xml…